First Commercial Use of Lombard Medical's IntelliFlex LP Delivery System for the Aorfix EVAR Device Performed in Spain

June 30, 2016—Lombard Medical, Inc. announced the first commercial use of its new IntelliFlex low-profile (LP) delivery system to implant the company’s Aorfix endovascular stent graft. The procedure was completed by Nilo J. Mosquera, MD, Head of the Department of Angiology and Vascular Surgery at Complexo Hospitalario Universitario de Ourense, Spain.

On June 21, the company announced that the IntelliFlex received European CE Mark approval. Lombard Medical will begin shipments of IntelliFlex in July to its direct markets in the United Kingdom and Germany, and expects a full commercial launch in the other European markets later in the year.

In the company’s announcement, Dr. Mosquera commented, “My surgical team and I were very pleased with the performance of IntelliFlex LP. The device’s lower catheter profile was able to successfully navigate this particular patient’s calcified access vessels, something that in our experience might have not been possible with the previous generation’s delivery profile. The enhanced control of the new Y-mechanism is a significant improvement in stent delivery technology and provides greater control and precision when deploying the proximal end of the devices, allowing for a very precise graft placement. The integrated exchange sheath is also beneficial in reducing potential vessel trauma and facilitates the less invasive percutaneous approach.” Dr. Mosquera added that the new IntelliFlex delivery system is simple, intuitive, and easy to use.